Multiple Sclerosis TopicsShow More
The new medications, siponimod (Mayzent, Novartis) and cladribine (Mavenclad, EMD Serono), bring treatment options to active secondary progressive multiple sclerosis (SPMS). Most treatments approved for MS are for relapsing, rather than progressive, forms of the disease.
Multiple sclerosis treatment is one of the fastest moving areas of medicine.
A number of disease-modifying therapies (DMTs) are effective in decreasing the frequency of relapses and the number of lesions in the brain or spinal cord.
Patients living with multiple sclerosis (MS) in the US may try these disease-modifying therapies (DMTs) to slow down the long-term progression of the disease.
Several medications used for MS are injectable drugs — aka, shots. We’ve been running from shots since we were kids, but they don’t have to hurt as badly as we remember. Here are some simple tips to minimize the pain, while maximizing the treatment.
Lisa Emrich features favorite MS articles of 2018 in this comprehensive list.
Attention MS patients: Anyone taking a medication or following a course of therapy has research to thank. Consider giving back to the body of knowledge.
Don’t let the flu throw your MS into hyperdrive. Reduce your risk of illness and know how to fight off influenza this season with these tips.
Living in a rural area may make finding care and support more difficult. Try these resources to help you through your MS journey.
Jackie Zimmerman articulates what MS patients need from their neurologists at the time of diagnosis and throughout their treatment, and shares lessons learned.